ホーム > 研究業績
研究業績
- Wen XZ, Akiyama Y, Pan KF, Liu ZJ, Lu ZM, Zhou J, Gu LK, Dong CX, Zhu BD, Ji JF, You WC, Deng DJ: Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J. Gastroenterol. 2010:16:1201–1208.
- Yuasa Y: Epigenetics in molecular epidemiology of cancer: a new scope. Adv Genet. 2010:71:211-235.
- Oze I, Matsuo K, Hosono S, Ito H, Kawase T, Watanabe M, Suzuki T, Hatooka S, Yatabe Y, Hasegawa Y, Shinoda M, Tajima K, Tanaka H: Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for the risk of upper aerodigestive tract cancer in a Japanese population. Cancer Sci. 2010:101:1875-1880.
- Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y: MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 2011: 6: e16617.
- Mimata A, Fukamachi H, Eishi Y, Yuasa Y: Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci. 2011:102:942-950.
- Fukamachi H, Shimada S, Ito K, Ito Y, Yuasa Y. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation. Cancer Sci. 2011:102:1313-1321.
- Nakao M, Matsuo K, Hosono S, Ogata S, Ito H, Watanabe M, Mizuno N, Iida S, Satoh S, Yatabe Y, Yamao K, Ueda R, Tajima K, Tanaka H: ABO blood group alleles and the risk of pancreatic cancer in Japanese population. Cancer Sci. 2011:102;1076-1080.
- Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y: MiR-9 down-regulates CDX2 expression in gastric cancer cells. Int. J. Cancer 2011, in press.
- Shimada S, Mimata A, Sekine M, Mogushi K, Akiyama Y, Fukamachi H, Jonkers J, Tanaka H, Eishi Y, Yuasa Y. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut, in press.
- Kawakita D, Matsuo K, Sato F, Oze I, Hosono S, Ito H, Watanabe M, Yatabe Y, Hanai N, Hasegawa Y, Tajima K, Murakami S, Tanaka H: Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. Ann. Oncol., in press.



